Prateek Singh

Prateek Singh

Director Director DIN 09275774
DIN 09275774 First appointment Aug 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2021
Shareholding value •••• Premium profile

About Prateek Singh

Data last updated:

Prateek Singh was a Director at Leafline Clinical Services Private Limited (2021–2022) and Director at Just 4U Consultancy Private Limited (2021–2024). The companies operate in Healthcare and Business Services.

DIN 09275774
Primary Designation Director
Industry Healthcare
First Appointment 10 Aug 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Aug 20212021Active
Just 4U Consultancy Private Limited U74999DL2021PTC385901
Director01 Sep 20212021₹20,000 (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Leafline Clinical Services Private Limited
Just 4U Consultancy Private Limited
Premium access

Shareholding and investment profile for Prateek Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prateek Singh

Prateek Singh was first appointed on 10 Aug 2021 as Director at Leafline Clinical Services Private Limited.

Prateek Singh held 2 earlier board appointments: Leafline Clinical Services Private Limited (Director, 10 Aug 2021 to 01 Feb 2022); Just 4U Consultancy Private Limited (Director, 01 Sep 2021 to 01 Mar 2024).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available